https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=GAMIDA_CELL_LTDGAMIDA CELL LTD - Revizia istoricului2026-05-17T16:52:18ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=GAMIDA_CELL_LTD&diff=421961&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei GAMIDA CELL LTD listata cu simbolul US.GMDA ==Descriere companie== Gamida Cell Ltd (www.gamida-cell.com) is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies. The foll...2024-09-18T17:59:34Z<p>Pagină nouă: Pagina dedicata companiei GAMIDA CELL LTD listata cu simbolul US.GMDA ==Descriere companie== Gamida Cell Ltd (www.gamida-cell.com) is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies. The foll...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei GAMIDA CELL LTD listata cu simbolul US.GMDA<br />
<br />
==Descriere companie==<br />
Gamida Cell Ltd (www.gamida-cell.com) is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies. The following are the Company's clinical pipeline products: NiCord, which is evaluated in a Phase III study in patients with high-risk blood cancers as well as in a Phase SS study in patients with severe aplastic anemia, as well as NAM-NK, an innate immunotherapy for the treatment of hematologic and solid tumors, which is investigated in a Phase I investigator-sponsored trial for the treatment of relapsed or refractory non-Hodgkin lymphoma (NHL), and multiple myeloma (MM).<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.GMDA" /><br />
<br />
==Ultimele stiri despre GAMIDA CELL LTD (US.GMDA)==<br />
<dynamicpagelist><br />
category=US.GMDA<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.GMDA]][[Categorie:Stiri despre companii]]</div>Admin